\-\ Texto\\:\\ \ \(0\)\
\-\ unknown\ \(157\)\
\-\ unknown\\;\\ however\\,\\ the\\ patient\\ should\\ have\\ a\\ follow\\-up\\ mri\\ to\\ exclude\\ multiple\\ sclerosis\\.\ \(0\)\
\-\ although\\ adem\\ more\\ commonly\\ involves\\ the\\ white\\ matter\\,\\ especially\\ in\\ the\\ subcortical\\ region\\,\\ the\\ gray\\ matter\\ may\\ also\\ be\\ involved\\.\\ \\ on\\ mri\\ patients\\ typically\\ present\\ with\\ multiple\\ foci\\ of\\ hyperintensity\\ on\\ t2w\\ images\\.\\ \\ these\\ lesions\\ may\\ or\\ may\\ not\\ be\\ associated\\ with\\ enhancement\\.\\ \\ in\\ that\\ adem\\ is\\ a\\ monophasic\\ process\\,\\ no\\ new\\ lesions\\ should\\ develop\\ after\\ 6\\ months\\ following\\ clinical\\ presentation\\.\ \(0\)\
\-\ acute\\ disseminated\\ encephalomyelitis\\ \\(adem\\)\ \(0\)\
\-\ adem\ \(8\)\
\-\ multiple\\ sclerosis\ \(41\)\
\-\ lyme\\ disease\ \(3\)\
\-\ neurosarcoid\ \(5\)\
\-\ lymphoma\ \(373\)\
\-\ progressive\\ multifocal\\ leukencephalopathy\ \(0\)\
\-\ 20\\ y\\.o\\.\\ man\\ who\\ developed\\ seizures\\ 2\\ weeks\\ after\\ receiving\\ the\\ small\\ pox\\ vaccination\\.\ \(1\)\
\-\ this\\ case\\ nicely\\ shows\\ the\\ multiple\\ t2\\ hyperintensities\\ scattered\\ throughout\\ the\\ deep\\ white\\ matter\\ in\\ the\\ brain\\ and\\ c\\-spine\\ in\\ a\\ patient\\ who\\ recently\\ received\\ the\\ small\\ pox\\ vaccination\\.\\ \\ he\\ clinically\\ presented\\ with\\ new\\ onset\\ seizures\\.\\ \\ as\\ this\\ is\\ a\\ new\\ finding\\ in\\ this\\ patient\\,\\ it\\ was\\ recommended\\ to\\ obtain\\ a\\ follow\\-up\\ mri\\ to\\ exclude\\ multiple\\ sclerosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adem\\:\\ 0\\.11577430961431127\ \(0\)\
\-\ pox\\:\\ 0\\.08347442767243379\ \(0\)\
\-\ vaccination\\:\\ 0\\.07436285220932896\ \(0\)\
\-\ matter\\:\\ 0\\.05670471860226063\ \(0\)\
\-\ sclerosis\\:\\ 0\\.05173003202403952\ \(0\)\
\-\ exclude\\:\\ 0\\.050998340505061156\ \(0\)\
\-\ multiple\\:\\ 0\\.05055634841233901\ \(0\)\
\-\ new\\:\\ 0\\.050187437811245364\ \(0\)\
\-\ leukencephalopathy\\:\\ 0\\.04952538440430617\ \(0\)\
\-\ seizures\\:\\ 0\\.04127926817375099\ \(0\)\
\-\ monophasic\\:\\ 0\\.03945931997044069\ \(0\)\
\-\ unknown\\:\\ 0\\.03747055618679221\ \(0\)\
\-\ neurosarcoid\\:\\ 0\\.03718142610466448\ \(0\)\
\-\ hyperintensities\\:\\ 0\\.03394904326812762\ \(0\)\
\-\ mri\\:\\ 0\\.03308891890305539\ \(0\)\
\-\ nicely\\:\\ 0\\.032421325765410534\ \(0\)\
\-\ encephalomyelitis\\:\\ 0\\.032159977362967315\ \(0\)\
\-\ white\\:\\ 0\\.03184386755856199\ \(0\)\
\-\ may\\:\\ 0\\.0315898039701931\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.03123637069035665\ \(0\)\
\-\ should\\:\\ 0\\.030609084740323596\ \(0\)\
\-\ obtain\\:\\ 0\\.030417533945530012\ \(0\)\
\-\ lyme\\:\\ 0\\.029714370221069306\ \(0\)\
\-\ c\\-spine\\:\\ 0\\.029393255536575215\ \(0\)\
\-\ subcortical\\:\\ 0\\.02923932871529367\ \(0\)\
\-\ disseminated\\:\\ 0\\.02923932871529367\ \(0\)\
\-\ receiving\\:\\ 0\\.027777064118306785\ \(0\)\
\-\ t2w\\:\\ 0\\.026911049063097464\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.026430587414568465\ \(0\)\
\-\ multifocal\\:\\ 0\\.02582028493702467\ \(0\)\
\-\ lesions\\:\\ 0\\.025702927037572446\ \(0\)\
\-\ who\\:\\ 0\\.025033352911704516\ \(0\)\
\-\ develop\\:\\ 0\\.0239418063616065\ \(0\)\
\-\ gray\\:\\ 0\\.023487581099645292\ \(0\)\
\-\ recently\\:\\ 0\\.022400026329574142\ \(0\)\
\-\ scattered\\:\\ 0\\.022355261331545057\ \(0\)\
\-\ involves\\:\\ 0\\.022310850210718578\ \(0\)\
\-\ received\\:\\ 0\\.022310850210718578\ \(0\)\
\-\ small\\:\\ 0\\.02211882342001257\ \(0\)\
\-\ clinically\\:\\ 0\\.02104839450419251\ \(0\)\
\-\ foci\\:\\ 0\\.020606876107601375\ \(0\)\
\-\ involved\\:\\ 0\\.020137133747819728\ \(0\)\
\-\ recommended\\:\\ 0\\.01990179137866714\ \(0\)\
\-\ after\\:\\ 0\\.01986518205178879\ \(0\)\
\-\ especially\\:\\ 0\\.01975955650235091\ \(0\)\
\-\ deep\\:\\ 0\\.019432203085924075\ \(0\)\
\-\ progressive\\:\\ 0\\.018974377050805073\ \(0\)\
\-\ process\\:\\ 0\\.018483513959745585\ \(0\)\
\-\ developed\\:\\ 0\\.018483513959745585\ \(0\)\
\-\ commonly\\:\\ 0\\.01811534518795304\ \(0\)\
\-\ throughout\\:\\ 0\\.017970490597190598\ \(0\)\
\-\ 20\\:\\ 0\\.017261321551443908\ \(0\)\
\-\ typically\\:\\ 0\\.016946212188235797\ \(0\)\
\-\ presentation\\:\\ 0\\.016535958620736417\ \(0\)\
\-\ although\\:\\ 0\\.016213085845935976\ \(0\)\
\-\ this\\:\\ 0\\.016198941797429207\ \(0\)\
\-\ finding\\:\\ 0\\.015472255646283602\ \(0\)\
\-\ onset\\:\\ 0\\.015154051831040167\ \(0\)\
\-\ be\\:\\ 0\\.014806255318471113\ \(0\)\
\-\ clinical\\:\\ 0\\.014771403371157326\ \(0\)\
\-\ brain\\:\\ 0\\.014445795074734617\ \(0\)\
\-\ patient\\:\\ 0\\.014436942655894179\ \(0\)\
\-\ 6\\:\\ 0\\.014337753715589182\ \(0\)\
\-\ y\\.o\\:\\ 0\\.013856064228015169\ \(0\)\
\-\ lymphoma\\:\\ 0\\.013720217047131942\ \(0\)\
\-\ following\\:\\ 0\\.013625155937646901\ \(0\)\
\-\ weeks\\:\\ 0\\.013625155937646901\ \(0\)\
\-\ t2\\:\\ 0\\.013587577352530068\ \(0\)\
\-\ region\\:\\ 0\\.013559557456400632\ \(0\)\
\-\ he\\:\\ 0\\.013394310910297863\ \(0\)\
\-\ however\\:\\ 0\\.013367236267399272\ \(0\)\
\-\ shows\\:\\ 0\\.01319872865016224\ \(0\)\
\-\ months\\:\\ 0\\.013112029745449815\ \(0\)\
\-\ presented\\:\\ 0\\.013086278848440502\ \(0\)\
\-\ enhancement\\:\\ 0\\.01286791441642155\ \(0\)\
\-\ these\\:\\ 0\\.012493509505381124\ \(0\)\
\-\ patients\\:\\ 0\\.01242457640093273\ \(0\)\
\-\ more\\:\\ 0\\.012006608479281833\ \(0\)\
\-\ acute\\:\\ 0\\.011853254657901659\ \(0\)\
\-\ in\\:\\ 0\\.011837000846636374\ \(0\)\
\-\ \\;\\:\\ 0\\.011378770721643785\ \(0\)\
\-\ man\\:\\ 0\\.011353549680280893\ \(0\)\
\-\ associated\\:\\ 0\\.011328441359032033\ \(0\)\
\-\ a\\:\\ 0\\.011140443871309025\ \(0\)\
\-\ present\\:\\ 0\\.010842745808604948\ \(0\)\
\-\ it\\:\\ 0\\.010791283059174251\ \(0\)\
\-\ case\\:\\ 0\\.010502833892512756\ \(0\)\
\-\ have\\:\\ 0\\.01039571954137692\ \(0\)\
\-\ 2\\:\\ 0\\.010337665710733406\ \(0\)\
\-\ also\\:\\ 0\\.009464155020618828\ \(0\)\
\-\ images\\:\\ 0\\.009209347707580641\ \(0\)\
\-\ that\\:\\ 0\\.008292026564937209\ \(0\)\
\-\ on\\:\\ 0\\.008133606880510428\ \(0\)\
\-\ disease\\:\\ 0\\.007846840119189348\ \(0\)\
\-\ \\,\\:\\ 0\\.007604215323519308\ \(0\)\
\-\ as\\:\\ 0\\.007261671381427684\ \(0\)\
\-\ to\\:\\ 0\\.007197777108589656\ \(0\)\
\-\ the\\:\\ 0\\.006990132372655237\ \(0\)\
\-\ not\\:\\ 0\\.006937183549111997\ \(0\)\
\-\ is\\:\\ 0\\.0063178739144351195\ \(0\)\
\-\ or\\:\\ 0\\.005626532297548919\ \(0\)\
\-\ was\\:\\ 0\\.005552120911312847\ \(0\)\
\-\ no\\:\\ 0\\.004833955902830348\ \(0\)\
\-\ \\(\\:\\ 0\\.004058211945190227\ \(0\)\
\-\ \\)\\:\\ 0\\.004008638719737669\ \(0\)\
\-\ \\.\\:\\ 0\\.0019943559605250715\ \(0\)\
\-\ with\\:\\ 0\\.001971980495897018\ \(0\)\
\-\ and\\:\\ 0\\.001011286549057407\ \(0\)\
\-\ of\\:\\ 0\\.0006545157348201597\ \(0\)\
